Uchrin and CFO Bhavesh Shah to attend and speak at the annual investor conference
NASHVILLE, Tenn. (December 19, 2024) — Monogram Health will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 13-16, 2025. The invitation is a testament to the significant growth of Monogram Health as it enters its sixth year of providing value-based care for patients with polychronic conditions.
CEO and co-founder Mike Uchrin will speak to investors on Monday, January 13, 2025 at 2 p.m. PST.
About Monogram Health
Monogram Health is the leading multispecialty provider of in-home, evidence-based care for patients with multiple chronic conditions. Unique to healthcare, Monogram Health does not silo itself by specialty, rather it takes a comprehensive and personalized approach to a person’s health, simultaneously evaluating and treating the whole person and all chronic conditions that are present – such as diabetes, hypertension, chronic kidney disease, heart failure, depression, COPD, and other metabolic disorders.
Monogram Health employs a robust and integrated clinical team, leveraging specialists across multiple disciplines (including nephrology, cardiology, endocrinology, pulmonology, behavioral health, and palliative/end of life care) to diagnose and treat all present and prevalent chronic conditions; review and prescribe medication; provide guidance, education, and counselling on a patient’s healthcare options; as well as assist with daily needs such as access to food, eating healthy, obtaining transportation, financial assistance, and more. Monogram Health is available 24 hours a day, 7 days a week, and on holidays, to support and treat patients in their home.
Monogram Health’s innovative treatment model and corresponding care plans are personalized and customized to each patient and proven to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Monogram Health is based in Nashville, Tennessee, operates throughout much of the U.S., and is privately held by Frist Cressey Ventures, Norwest Venture Partners, TPG Capital, and other leading strategic and financial investors. To learn more about Monogram Health, ranked by Inc. Magazine as the 3rd fastest growing private company in the United States in 2024 and 7th in 2025, please visit here.
###
